Montreal, Canada

Sebastien Francoeur

This inventor holds 1 USPTO granted patent. Top assignee: Merck Frosst Canada & Co.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastien Francoeur. Retrieved from https://idiyas.com/inventor/sebastien-francoeur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sebastien Francoeur

Introduction

Sebastien Francoeur is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have potential therapeutic applications. His work is characterized by a focus on innovative solutions to complex biological problems.

Latest Patents

Sebastien Francoeur holds a patent for "Gamma-ketoacid dipeptides as inhibitors of caspase-3." This patent represents a breakthrough in the understanding of caspase-3 inhibition, which is crucial for various therapeutic interventions. The compounds he developed are represented by a specific formula, showcasing his expertise in chemical innovation.

Career Highlights

Currently, Sebastien is employed at Merck Frosst Canada & Co., where he continues to push the boundaries of scientific research and development. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biochemistry.

Collaborations

Throughout his career, Sebastien has worked alongside esteemed colleagues such as Yongxin Han and Andre Giroux. These collaborations have enriched his research and have led to advancements in their shared field of study.

Conclusion

Sebastien Francoeur's work exemplifies the spirit of innovation in the scientific community. His patent and ongoing research at Merck Frosst Canada & Co. highlight his commitment to advancing biochemistry and developing new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…